Bullish option flow detected in Crispr Therapeutics (CRSP) with 3,734 calls trading, 1.3x expected, and implied vol increasing almost 4 points to 54.16%. Jul-25 60 calls and 1/31 weekly 39 puts are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.24. Earnings are expected on February 19th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Cathie Wood’s ARK Investment bought 147K shares of Crispr Therapeutics today
- Cathie Wood’s ARK Invest Boosts CRISPR Therapeutics (NASDAQ:CRSP) Stake
- Cathie Wood’s ARK Investment bought 133K shares of Crispr Therapeutics today
- Crispr Therapeutics highlights strategic priorities, anticipated milestones
- Crispr Therapeutics proposes to elect Briggs Morrison to board